MedPath

Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers

Phase 2
Completed
Conditions
Cigarette Smoking
Interventions
Behavioral: Self-Help Manual
Behavioral: Mail-based Self-help plus Internet-based Smoking Treatment
Behavioral: Self-Help Manual plus Telephone counseling
Behavioral: Self-Help Manual plus Internet-based Intervention plus Telephone Counseling
Registration Number
NCT00634218
Lead Sponsor
University of California, San Francisco
Brief Summary

Smoking rates are significantly higher among lesbian, gay, bisexual, and transgender (LGBT) populations compared to the general population. LGBT individuals may be at increased risk for experiencing psychosocial issues, e.g., negative moods, stress, alcohol/drug use, that have been associated with smoking treatment failure in other groups of smokers. Technology, such as the Internet and telephone, can be an effective method to reach a large number of smokers and may be particularly effective in reaching hidden populations. Thus, the study seeks to examine whether Internet-based counseling and/or telephone counseling can improve quit rates for LGBT smokers.

Participants (N=600) will be randomly assigned to one of four conditions: 1) a Mail-based Self Help (MSH) treatment; 2) MSH plus an Internet-based Smoking Treatment (IST); MSH plus Telephone Counseling (TC) or 4) MSH plus IST plus TC. Participants in the MSH condition will receive a self-help smoking cessation manual. In the IST condition, participants will receive the manual plus access to an Internet-based intervention that includes social support. In the TC condition, participants will receive the manual plus 6 telephone-based counseling sessions. In the fourth condition, participants will receive the manual plus access to an Internet-based intervention plus telephone counseling. Before starting treatment, participants will complete questionnaires on smoking, nicotine dependence, demographics, negative mood, and alcohol use. Participants will be contacted at 3, 6, and 12 months after enrollment to determine whether they are smoking. The data will be analyzed to compare the efficacy of the four treatments and to examine the possible influence of existing social networks and level of negative mood on treatment outcome and to examine the possible influence of residency (rural versus urban) on use of the Internet-based treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
363
Inclusion Criteria
  • 18 years of age
  • identify as lesbian, gay, bisexual, or transgender
  • access to the internet
  • valid email account
  • valid telephone number
  • English speaking
  • resident of the U.S.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
1Self-Help ManualMail-based Self Help (MSH) treatment. Participants will receive the self-help manual developed specifically for LGBT smokers.
2Mail-based Self-help plus Internet-based Smoking TreatmentMail-based Self Help plus an Internet-based Smoking Treatment (IST). In the IST condition, participants will receive the manual plus access to an Internet-based intervention that includes social support.
3Self-Help Manual plus Telephone counselingMail-based Self-Help plus Telephone Counseling (TC). In the TC condition, participants will receive a self-help manual specifically developed for LGBT smokers plus 6 telephone-based counseling sessions.
4Self-Help Manual plus Internet-based Intervention plus Telephone CounselingMail-based Self-Help plus an Internet-based Intervention plus Telephone Counseling. Participants will receive a self-help manual, have access to an internet-based smoking treatment and participante in 6 telephone counseling sessions.
Primary Outcome Measures
NameTimeMethod
Smoking status3,6, and 12 months following enrollment.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Univeristy of California, San Francisco

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath